By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Karyopharm Therapeutics 

Newton  Massachusetts    U.S.A.
Phone: n/a Fax: n/a



Company News
Karyopharm (KPTI) To Present At The 15th Annual BIO Investor Forum 10/11/2016 8:07:47 AM
Karyopharm (KPTI) To Present Updated SIGN Phase II Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting 10/5/2016 7:49:10 AM
Karyopharm (KPTI) Publishes Preclinical Data In Nature Demonstrating Selinexor’s Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) 9/29/2016 7:42:31 AM
Karyopharm (KPTI) Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication 9/28/2016 7:24:21 AM
Karyopharm (KPTI) Touts Mid-Stage Data, May See Quicker Approval of Multiple Myeloma Drug 9/6/2016 6:58:06 AM
5 Biotechs Under $10 With Massive Potential 9/6/2016 6:19:02 AM
Karyopharm (KPTI) To Host Conference Call With Update On Multiple Myeloma Plans 8/31/2016 7:51:49 AM
Karyopharm (KPTI) Reports Second Quarter 2016 Financial Results And Highlights Recent Progress 8/4/2016 11:24:31 AM
Karyopharm (KPTI) To Present At Upcoming Investor Conferences 8/3/2016 8:46:13 AM
Karyopharm (KPTI) To Present Updated Phase II Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting 7/28/2016 10:38:47 AM